0001209191-24-000919.txt : 20240104 0001209191-24-000919.hdr.sgml : 20240104 20240104193223 ACCESSION NUMBER: 0001209191-24-000919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heery Christopher CENTRAL INDEX KEY: 0001789632 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41259 FILM NUMBER: 24514022 MAIL ADDRESS: STREET 1: C/O PRECISION BIOSCIENCES, INC. STREET 2: 302 E. PETTIGREW STREET, SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcellx, Inc. CENTRAL INDEX KEY: 0001786205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472855917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 WEST WATKINS MILL ROAD STREET 2: SUITE A CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-723-6641 MAIL ADDRESS: STREET 1: 25 WEST WATKINS MILL ROAD STREET 2: SUITE A CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-02 0 0001786205 Arcellx, Inc. ACLX 0001789632 Heery Christopher C/O ARCELLX, INC. 25 WEST WATKINS MILL ROAD, SUITE A GAITHERSBURG MD 20878 0 1 0 0 Chief Medical Officer 0 Common Stock 2024-01-03 4 M 0 16519 0.00 A 25457 D Stock Option (right to buy) 56.15 2024-01-02 4 A 0 60096 0.00 A 2034-01-02 Common Stock 60096 60096 D Restricted Stock Unit 2024-01-02 4 A 0 39063 0.00 A Common Stock 39063 39063 D Restricted Stock Unit 2024-01-03 4 M 0 16519 0.00 D Common Stock 16519 33039 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Includes 753 shares acquired under the Issuer's 2022 Employee Stock Purchase Plan on May 12, 2023 and 390 shares acquired under the Issuer's 2022 Employee Stock Purchase Plan on November 14, 2023. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option will vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (or, if there is no corresponding day in a particular month, then the last day of the month) over four (4) years. "Vesting Commencement Date" shall mean January 1, 2024. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the RSUs subject to the award will vest each year following the RSU Grant Date on the same day of the month as the RSU Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "RSU Grant Date" shall mean January 2, 2024. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the RSUs subject to the award will vest each year following the RSU Grant Date on the same day of the month as the RSU Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "RSU Grant Date" shall mean January 3, 2023. /s/ Michelle Gilson, as Attorney-in-Fact 2024-01-04